Astera Labs (NASDAQ:ALAB) Given New $100.00 Price Target at Deutsche Bank Aktiengesellschaft

Astera Labs (NASDAQ:ALAB) had its target price boosted by Deutsche Bank Aktiengesellschaft from $60.00 to $100.00 in a research note issued on Tuesday, Benzinga reports. The firm presently has a “buy” rating on the stock. Deutsche Bank Aktiengesellschaft’s target price would indicate a potential upside of 1.86% from the company’s current price.

Other equities research analysts also recently issued research reports about the stock. Morgan Stanley lifted their price target on shares of Astera Labs from $55.00 to $74.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 9th. Barclays decreased their price target on shares of Astera Labs from $85.00 to $70.00 and set an “overweight” rating on the stock in a research note on Wednesday, August 7th. JPMorgan Chase & Co. reduced their target price on shares of Astera Labs from $95.00 to $70.00 and set an “overweight” rating on the stock in a research note on Wednesday, August 7th. Stifel Nicolaus reduced their target price on shares of Astera Labs from $87.00 to $80.00 and set a “buy” rating on the stock in a research note on Monday, August 5th. Finally, Roth Mkm reduced their target price on shares of Astera Labs from $85.00 to $60.00 and set a “buy” rating on the stock in a research note on Wednesday, August 7th. Eleven equities research analysts have rated the stock with a buy rating, According to MarketBeat, Astera Labs currently has a consensus rating of “Buy” and an average target price of $92.36.

Astera Labs Stock Up 2.4 %

Shares of ALAB stock opened at $98.17 on Tuesday. Astera Labs has a 1 year low of $36.22 and a 1 year high of $98.68. The firm’s fifty day simple moving average is $57.00 and its 200 day simple moving average is $58.39.

Astera Labs (NASDAQ:ALAB) last posted its quarterly earnings results on Monday, November 4th. The company reported $0.23 earnings per share for the quarter, topping analysts’ consensus estimates of $0.17 by $0.06. The business had revenue of $113.10 million for the quarter, compared to analyst estimates of $97.50 million. The company’s quarterly revenue was up 47.1% compared to the same quarter last year. On average, analysts anticipate that Astera Labs will post -0.54 earnings per share for the current year.

Insider Activity at Astera Labs

In related news, insider Sanjay Gajendra sold 110,000 shares of Astera Labs stock in a transaction dated Friday, October 11th. The stock was sold at an average price of $69.47, for a total value of $7,641,700.00. Following the completion of the transaction, the insider now directly owns 835,000 shares of the company’s stock, valued at $58,007,450. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. In other Astera Labs news, General Counsel Philip Mazzara sold 8,000 shares of the business’s stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $43.12, for a total transaction of $344,960.00. Following the completion of the sale, the general counsel now directly owns 325,474 shares of the company’s stock, valued at approximately $14,034,438.88. The trade was a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, insider Sanjay Gajendra sold 110,000 shares of the business’s stock in a transaction dated Friday, October 11th. The stock was sold at an average price of $69.47, for a total value of $7,641,700.00. Following the sale, the insider now directly owns 835,000 shares of the company’s stock, valued at $58,007,450. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 564,458 shares of company stock valued at $31,970,841 over the last ninety days.

Institutional Trading of Astera Labs

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Sei Investments Co. bought a new stake in shares of Astera Labs in the 1st quarter valued at about $952,000. Vanguard Group Inc. bought a new stake in shares of Astera Labs in the 1st quarter valued at about $127,268,000. Forge First Asset Management Inc. bought a new stake in shares of Astera Labs in the 1st quarter valued at about $1,143,000. Price T Rowe Associates Inc. MD bought a new stake in shares of Astera Labs in the 1st quarter valued at about $44,514,000. Finally, Jennison Associates LLC bought a new stake in shares of Astera Labs in the 1st quarter valued at about $11,283,000.

Astera Labs Company Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.